Pfizer has formed a partnership to manufacture some of its drugs in the rapidly growing Asian market.

With the government shutdown now in its fourth week, FDA Commissioner Scott Gottlieb says about 260 medical product inspectors have been recalled.

Pfizer is offering some 1,700 door-heading employees "an attractive financial scheme that is significantly higher than the legal requirements."

AstraZeneca said the move is meant to "consolidate the biologics manufacturing network" at one large site in Maryland.

FDA slaps Akorn with warning letter following an inspection of its sterile injectables plant in Illinois.

Here are some other manufacturing news stories we're following.

Mylan shelled out $9.4 million for Ascendis Health’s South African manufacturing plant that is focused on producing antiretrovirals to combat HIV.

Sun Pharma is recalling four lots of the muscle relaxant vecuronium bromide after glass fragments were found.